402 related articles for article (PubMed ID: 16554355)
21. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
Buschauer A
J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
[TBL] [Abstract][Full Text] [Related]
22. The human histamine H2-receptor couples more efficiently to Sf9 insect cell Gs-proteins than to insect cell Gq-proteins: limitations of Sf9 cells for the analysis of receptor/Gq-protein coupling.
Houston C; Wenzel-Seifert K; Bürckstümmer T; Seifert R
J Neurochem; 2002 Feb; 80(4):678-96. PubMed ID: 11841575
[TBL] [Abstract][Full Text] [Related]
23. Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.
Geyer R; Nordemann U; Strasser A; Wittmann HJ; Buschauer A
J Med Chem; 2016 Apr; 59(7):3452-70. PubMed ID: 27007611
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor.
Bruysters M; Jongejan A; Gillard M; van de Manakker F; Bakker RA; Chatelain P; Leurs R
Mol Pharmacol; 2005 Apr; 67(4):1045-52. PubMed ID: 15626750
[TBL] [Abstract][Full Text] [Related]
25. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
Wittmann HJ; Seifert R; Strasser A
Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
[TBL] [Abstract][Full Text] [Related]
26. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
Strasser A; Wittmann HJ; Seifert R
J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
[TBL] [Abstract][Full Text] [Related]
27. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
[TBL] [Abstract][Full Text] [Related]
29. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
30. The pharmacological activity of some new fluorescent small molecule histamine H2 receptor (H2-R) ligands, derived from aminopotentidine and squaramide, in the GTPase assay.
Petrache G; Pavelescu MD
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):255-9. PubMed ID: 20509312
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the H
Biselli S; Bresinsky M; Tropmann K; Forster L; Honisch C; Buschauer A; Bernhardt G; Pockes S
Eur J Med Chem; 2021 Mar; 214():113190. PubMed ID: 33548637
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
33. Side-chain modified analogues of histaprodifen: asymmetric synthesis and histamine H1-receptor activity.
Patil R; Elz S; Reiser O
Bioorg Med Chem Lett; 2006 Feb; 16(3):672-6. PubMed ID: 16266803
[TBL] [Abstract][Full Text] [Related]
34. G proteins of the Gq family couple the H2 histamine receptor to phospholipase C.
Kühn B; Schmid A; Harteneck C; Gudermann T; Schultz G
Mol Endocrinol; 1996 Dec; 10(12):1697-707. PubMed ID: 8961278
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists.
Govoni M; Bakker RA; van de Wetering I; Smit MJ; Menge WM; Timmerman H; Elz S; Schunack W; Leurs R
J Med Chem; 2003 Dec; 46(26):5812-24. PubMed ID: 14667234
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the binding site of the histamine H3 receptor. 1. Various approaches to the synthesis of 2-(1H-imidazol-4-yl)cyclopropylamine and histaminergic activity of (1R,2R)- and (1S,2S)-2-(1H-imidazol-4-yl)-cyclopropylamine.
De Esch IJ; Vollinga RC; Goubitz K; Schenk H; Appelberg U; Hacksell U; Lemstra S; Zuiderveld OP; Hoffmann M; Leurs R; Menge WM; Timmerman H
J Med Chem; 1999 Apr; 42(7):1115-22. PubMed ID: 10197956
[TBL] [Abstract][Full Text] [Related]
37. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
Wittmann HJ; Seifert R; Strasser A
Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
[TBL] [Abstract][Full Text] [Related]
38. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
39. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
[TBL] [Abstract][Full Text] [Related]
40. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
Igel P; Schnell D; Bernhardt G; Seifert R; Buschauer A
ChemMedChem; 2009 Feb; 4(2):225-31. PubMed ID: 19101971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
